RayThera
RayThera is dedicated to developing small molecule therapies specifically targeting unmet needs in immunology.
$110M Series A ·
Led by Foresite Capital · Source: fundraisingfox.com
Funding history ↓Acquired by BBiogen on for $1B · PMLiVE.
Signals
Website registeredOct 5, 2019 (7 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series A | $110M | fundraisingfox.com |
Timeline
Founders and team
GH
Gene Hung FounderQD
Qing Dong Founder
Investors
Companies like RayThera
CCoultreon$125M Series A · Apr 2026
QQuarry Thera$32M Series A · Jan 2026RRgenta TherapeuticsSeries B+ · Nov 2026
WWayfinder BiosciencesSSerna Bio
RRougeTx$58M Series A · Oct 2026
Other companies backed by Foresite Capital
Bbit.bio$25M Series B+ · Nov 2026
KKymaThera$80M Series B+ · Oct 2026
AAbcuro$66M Series B+ · Aug 2026
KKhartis Therapeutics$95M Series B+ · Aug 2026
LLifeMine Therapeutics$75M Series B+ · Aug 2026
SStepful$55M Series B+ · Jun 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/raythera (get a free API key).